Updates on CCP Virus: Moderna Develops New Vaccine for South African Variant

A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against COVID-19, in Cambridge, Mass., on May 18, 2020. Brian Snyder/Reuters

Moderna announced on Jan. 25 that it had developed a new  CCP virus vaccine to combat a new South African variant of the virus, with plans to advance it into a phase one study.

First detected in South Africa, the B.1.351 variant spreads faster and is more contagious, but there’s still no concrete evidence suggesting that it is deadlier.